A double-blind, placebo controlled, randomized trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the incidence of wound complications in patients with open surgery.
Phase 2
- Conditions
- Gastrointestinal malignant tumor
- Registration Number
- JPRN-UMIN000012553
- Lead Sponsor
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Previous abdominal operative scar. 2) Emergency surgery. 3) Uncontrollable diabetes millutus or administration of insulin. 4) Systemic steroids medication. 5) Active bacterial or fungous infection. 6) Other conditions judged as inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of wound complications
- Secondary Outcome Measures
Name Time Method The incidence of postoperative complications except wound complications, Postoperative hospital stay, muscle mass (skeletal muscle mass, grip strength), moisture content of the skin.